Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    August 2016
  1. WALKER Z, Moreno E, Thomas A, Inglis F, et al
    Evolution of clinical features in possible DLB depending on FP-CIT SPECT result.
    Neurology. 2016 Aug 10. pii: 10.1212/WNL.0000000000003076.
    PubMed     Text format     Abstract available


    July 2016
  2. CAVALLARO T, Klunk W
    PiB-PET detects transthyretin-related cerebral amyloid angiopathy.
    Neurology. 2016 Jul 27. pii: 10.1212/WNL.0000000000003018.
    PubMed     Text format    


  3. GOTTESMAN RF, Schneider AL, Zhou Y, Chen X, et al
    The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE.
    Neurology. 2016 Jul 1. pii: 10.1212/WNL.0000000000002914.
    PubMed     Text format     Abstract available


    June 2016
  4. CHO H, Choi JY, Hwang MS, Lee JH, et al
    Tau PET in Alzheimer disease and mild cognitive impairment.
    Neurology. 2016 Jun 29. pii: 10.1212/WNL.0000000000002892.
    PubMed     Text format     Abstract available


    May 2016

  5. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study.
    Neurology. 2016;86:2116.
    PubMed     Text format    


  6. WERNER P, Saur D, Mildner T, Moller H, et al
    Combined PET/MRI: Multimodality insights into acute stroke hemodynamics.
    Neurology. 2016;86:1926-7.
    PubMed     Text format    


    March 2016
  7. SCOTT G, Ramlackhansingh AF, Edison P, Hellyer P, et al
    Amyloid pathology and axonal injury after brain trauma.
    Neurology. 2016;86:821-8.
    PubMed     Text format     Abstract available


    February 2016
  8. VERA JH, Guo Q, Cole JH, Boasso A, et al
    Neuroinflammation in treated HIV-positive individuals: A TSPO PET study.
    Neurology. 2016 Feb 24. pii: 10.1212/WNL.0000000000002485.
    PubMed     Text format     Abstract available


  9. MARNANE M, Al-Jawadi OO, Mortazavi S, Pogorzelec KJ, et al
    Periventricular hyperintensities are associated with elevated cerebral amyloid.
    Neurology. 2016;86:535-43.
    PubMed     Text format     Abstract available


    January 2016
  10. NERRANT E, Fourcade C, Coulette S, Lechiche C, et al
    Teaching NeuroImages: Extensive vasogenic edema in Bickerstaff brainstem encephalitis.
    Neurology. 2016;86:e38-9.
    PubMed     Text format    


  11. RUSSELL DS, Jennings DL, Barret O, Tamagnan GD, et al
    Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
    Neurology. 2016 Jan 22. pii: 10.1212/WNL.0000000000002391.
    PubMed     Text format     Abstract available


  12. STOESSL AJ
    Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
    Neurology. 2016;86:228.
    PubMed     Text format    


  13. DEL CAMPO N, Payoux P, Djilali A, Delrieu J, et al
    Relationship of regional brain beta-amyloid to gait speed.
    Neurology. 2016;86:36-43.
    PubMed     Text format     Abstract available


    December 2015
  14. PAYER DE, Guttman M, Kish SJ, Tong J, et al
    D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia.
    Neurology. 2015 Dec 30. pii: 10.1212/WNL.0000000000002285.
    PubMed     Text format     Abstract available


  15. LOHLE M, Mende J, Wolz M, Beuthien-Baumann B, et al
    Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications.
    Neurology. 2015 Dec 30. pii: 10.1212/WNL.0000000000002286.
    PubMed     Text format     Abstract available


    November 2015
  16. CANOSA A, Pagani M, Cistaro A, Montuschi A, et al
    18F-FDG-PET correlates of cognitive impairment in ALS.
    Neurology. 2015 Nov 20. pii: 10.1212/WNL.0000000000002242.
    PubMed     Text format     Abstract available


  17. CHRISTENSEN S, Obi C, Albers G, Lansberg M, et al
    Ultra-acute CT perfusion imaging: A stroke in the scanner.
    Neurology. 2015;85:1725-6.
    PubMed     Text format    


    October 2015
  18. ZWAN MD, Rinne JO, Hasselbalch SG, Nordberg A, et al
    Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study.
    Neurology. 2015 Oct 14. pii: 10.1212/WNL.0000000000002081.
    PubMed     Text format     Abstract available


    September 2015
  19. PALMQVIST S, Zetterberg H, Mattsson N, Johansson P, et al
    Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000001991.
    PubMed     Text format     Abstract available


  20. LEE DH, Oh JS, Ham JH, Lee JJ, et al
    Is normosmic Parkinson disease a unique clinical phenotype?
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000001999.
    PubMed     Text format     Abstract available


    August 2015
  21. ALPERT JN, Saidha S, Al-Louzi O
    Biopsy-negative PET-positive giant-cell arteritis.
    Neurology. 2015;85:743.
    PubMed     Text format    


  22. NIRENBERG MJ
    Preoperative factors of apathy in subthalamic stimulated Parkinson disease: A PET study.
    Neurology. 2015;85:483.
    PubMed     Text format    


    July 2015
  23. LIU E, Schmidt ME, Margolin R, Sperling R, et al
    Amyloid-beta 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
    Neurology. 2015 Jul 24. pii: 10.1212/WNL.0000000000001877.
    PubMed     Text format     Abstract available


  24. BREITNER JC
    Yet another "disconnect" between amyloid and Alzheimer disease?
    Neurology. 2015 Jul 24. pii: 10.1212/WNL.0000000000001871.
    PubMed     Text format    


  25. TOLEDO JB, Bjerke M, Chen K, Rozycki M, et al
    Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings.
    Neurology. 2015;85:144-53.
    PubMed     Text format     Abstract available


  26. KIM HJ, Im K, Kwon H, Lee JM, et al
    Clinical effect of white matter network disruption related to amyloid and small vessel disease.
    Neurology. 2015;85:63-70.
    PubMed     Text format     Abstract available


  27. AMARIGLIO RE, Mormino EC, Pietras AC, Marshall GA, et al
    Subjective cognitive concerns, amyloid-beta, and neurodegeneration in clinically normal elderly.
    Neurology. 2015;85:56-62.
    PubMed     Text format     Abstract available


    June 2015
  28. COSGROVE J, Jamieson S, Chowdhury FU
    Teaching NeuroImages: Hypometabolism of the primary motor cortex in primary lateral sclerosis: The stripe sign.
    Neurology. 2015;84:e206.
    PubMed     Text format    


  29. JENNINGS D, Siderowf A, Stern M, Seibyl J, et al
    Author Response.
    Neurology. 2015;84:2292.
    PubMed     Text format    


  30. MULLER ML, Albin RL, Bohnen NI, Jennings D, et al
    Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study.
    Neurology. 2015;84:2292.
    PubMed     Text format    


    May 2015
  31. BRIDEL C, Garibotto V
    Teaching NeuroImages: Drug-induced parkinsonism with asymmetrical putaminal DaT binding.
    Neurology. 2015;84:e159.
    PubMed     Text format    


  32. LEVENTER RJ, Scerri T, Marsh AP, Pope K, et al
    Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR.
    Neurology. 2015;84:2029-32.
    PubMed     Text format     Abstract available


  33. CAMPBELL MC, Koller JM, Snyder AZ, Buddhala C, et al
    CSF proteins and resting-state functional connectivity in Parkinson disease.
    Neurology. 2015 May 15. pii: 10.1212/WNL.0000000000001681.
    PubMed     Text format     Abstract available


  34. GROWDON ME, Schultz AP, Dagley AS, Amariglio RE, et al
    Odor identification and Alzheimer disease biomarkers in clinically normal elderly.
    Neurology. 2015 May 1. pii: 10.1212/WNL.0000000000001614.
    PubMed     Text format     Abstract available


    April 2015
  35. IKAWA M, Okazawa H, Tsujikawa T, Matsunaga A, et al
    Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study.
    Neurology. 2015 Apr 22. pii: 10.1212/WNL.0000000000001588.
    PubMed     Text format     Abstract available


    January 2015
  36. SUCHORSKA B, Jansen NL, Linn J, Kretzschmar H, et al
    Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.
    Neurology. 2015 Jan 21. pii: 10.1212/WNL.0000000000001262.
    PubMed     Text format     Abstract available


  37. APOSTOLOVA LG, Hwang KS, Avila D, Elashoff D, et al
    Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.
    Neurology. 2015 Jan 21. pii: 10.1212/WNL.0000000000001231.
    PubMed     Text format     Abstract available


  38. JENNINGS D, Seibyl J, Sabbagh M, Lai F, et al
    Age dependence of brain beta-amyloid deposition in Down syndrome: An [18F]florbetaben PET study.
    Neurology. 2015 Jan 7. pii: 10.1212/WNL.0000000000001212.
    PubMed     Text format     Abstract available


  39. WING YK, Lam SP, Zhang J, Leung E, et al
    Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression.
    Neurology. 2015 Jan 7. pii: 10.1212/WNL.0000000000001215.
    PubMed     Text format     Abstract available


    November 2014
  40. SOUSSAN M, Medjoul A, Badelon I, Guillot A, et al
    IgG4-related diffuse perineural disease.
    Neurology. 2014;83:1877-8.
    PubMed     Text format    


  41. LOPEZ OL, Klunk WE, Mathis C, Coleman RL, et al
    Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old.
    Neurology. 2014;83:1804-11.
    PubMed     Text format     Abstract available


  42. RAMAN MR, Wiste HJ, Senjem ML, Ward CP, et al
    Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult.
    Neurology. 2014;83:1771-2.
    PubMed     Text format    


    October 2014
  43. JENNINGS D, Siderowf A, Stern M, Seibyl J, et al
    Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study.
    Neurology. 2014 Oct 8. pii: 10.1212/WNL.0000000000000960.
    PubMed     Text format     Abstract available


  44. AL-LOUZI O, Hauptman H, Saidha S
    Biopsy-negative PET-positive giant-cell arteritis.
    Neurology. 2014 Oct 1. pii: 10.1212/WNL.0000000000000940.
    PubMed     Text format    


    September 2014
  45. COHEN-AUBART F, Emile JF, Maksud P, Galanaud D, et al
    Marked efficacy of vemurafenib in suprasellar Erdheim-Chester disease.
    Neurology. 2014;83:1294-6.
    PubMed     Text format    


  46. ROBERT GH, Le Jeune F, Lozachmeur C, Drapier S, et al
    Preoperative factors of apathy in subthalamic stimulated Parkinson disease: A PET study.
    Neurology. 2014 Sep 24. pii: 10.1212/WNL.0000000000000941.
    PubMed     Text format     Abstract available


  47. HEMB M, Paglioli E, Dubeau F, Andermann F, et al
    "Mirror EPC": Epilepsia partialis continua shifting sides after rolandic resection in dysplasia.
    Neurology. 2014 Sep 12. pii: 10.1212/WNL.0000000000000878.
    PubMed     Text format     Abstract available


  48. BAUER M, Karch R, Zeitlinger M, Liu J, et al
    In vivo P-glycoprotein function before and after epilepsy surgery.
    Neurology. 2014 Sep 3. pii: 10.1212/WNL.0000000000000858.
    PubMed     Text format     Abstract available


    August 2014
  49. GRAFF-RADFORD J, Murray ME, Lowe VJ, Boeve BF, et al
    Dementia with Lewy bodies: basis of cingulate island sign.
    Neurology. 2014;83:801-9.
    PubMed     Text format     Abstract available


  50. PAGANI M, Chio A, Valentini MC, Oberg J, et al
    Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
    Neurology. 2014 Aug 13. pii: 10.1212/WNL.0000000000000792.
    PubMed     Text format     Abstract available


    July 2014
  51. VILLENEUVE S, Reed BR, Madison CM, Wirth M, et al
    Vascular risk and Abeta interact to reduce cortical thickness in AD vulnerable brain regions.
    Neurology. 2014;83:40-7.
    PubMed     Text format     Abstract available


    June 2014
  52. LOWE VJ, Weigand SD, Senjem ML, Vemuri P, et al
    Association of hypometabolism and amyloid levels in aging, normal subjects.
    Neurology. 2014;82:1959-67.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: